References
T. Herlin, K. Fogh, H. Ewald, E. S. Hansen, V. F. Knudsen, I. Holm, K. Kragballe and C. Bunger,Changes in lipoxygenase products from synovial fluid in carragheenan induced arthritis in dogs. APMIS96, 601 604 (1988).
J. Y. Vanderhoek, R. W. Bryant and J. M. Bailey,Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J. Biol. Chem.255, 10064–10066 (1980).
T. Ternowitz, K. Fogh and K. Kragballe,15-hydroxy-eicosatetraenoic acid (15-HETE) speeifically inhibits LTB 4-induced chemotaxis of human neutrophils. Skin Pharmacology1, 93 99 (1988).
K. Fogh, H. Søgaard, T. Herlin and K. Kragballe,Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxy-eicosatetraenoic acid (15-HETE). J. Am. Acad. Dermatol.18, 279–285 (1988).
K. Fogh, E. S. Hansen, T. Herlin, V. Knudsen, T. B. Henriksen, H. Ewald, C. Bunger and K. Kragballe,15-hydroxyeicosatetraenoic acid (15-HETE) inhibits carragheenan-induced experimental arthritis and reduces synovial fluid leukotriene B 4 (LTB 4). Prostaglandins37, 213 228 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herlin, T., Fogh, K., Hansen, E.S. et al. 15-HETE inhibits leukotriene B4 formation and synovial cell proliferation in experimental arthritis. Agents and Actions 29, 52–53 (1990). https://doi.org/10.1007/BF01964718
Issue Date:
DOI: https://doi.org/10.1007/BF01964718